HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Drug Discovery and Screening
  • In Vitro Models for Drug Screening

Drug discovery is a process where a new drug or medications are discovered and aims to identify a compound therapeutically useful in curing and treating disease. It includes a wide range of scientific divisions, including biology, chemistry, and pharmacology.

This process associates with the identification of candidates, synthesis, characterization, validation, optimization, screening, and assays for therapeutic efficacy.

The three major phases are:

  • Formulation,
  • Delivery,
  • Packaging Development

Drug Development Phases includes:

  • Phase 1: Discovery and Development.
  • Phase 2: Preclinical Research.
  • Phase 3: Clinical Research.
  • Phase 4: FDA Review.
  • Phase 5: FDA Post-Market Safety Monitoring.

Drug screening is a process where potential drugs are identified and optimized before the selection of a candidate drug to progress to clinical trials. It can involve screening large volumes of chemicals for a particular biological activity in high-throughput screening assays.

Drug screening mainly includes In-vivo and In-vivo models for drug screening

Committee Members
Speaker at Pharmaceutical Conference - Thomas J. Webster

Thomas J. Webster

Mansfield Bioincubator, United States
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
Speaker at Drug Delivery Events - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Speaker at Pharma Conferences - Saad Tayyab

Saad Tayyab

UCSI University, Malaysia
PDDS 2024 Speakers
Speaker at Drug Delivery Events -  Andreas M Papas

Andreas M Papas

Antares Health Products, United States
Speaker at Pharma Conferences - Luis Jesus Villarreal Gomez

Luis Jesus Villarreal Gomez

FCITEC - Universidad Autónoma de Baja California, Mexico
Speaker at Pharmaceutical Conference - Thomas Ullrich

Thomas Ullrich

Novartis Biomedical Research, Switzerland
Speaker at Pharma conferences - Afonin S.M

Afonin S.M

National Research University of Electronic Technology, Russian Federation
Speaker at Drug Delivery Events - Miroslav Radenkovic

Miroslav Radenkovic

University of Belgrade, Serbia
Speaker at Pharma conferences - Priya Hays

Priya Hays

Hays Documentation Specialists, LLC, United States

Submit your abstract Today